Pyrilamine Shortage: What Providers and Prescribers Need to Know in 2026

Pyrilamine maleate is a first-generation H1 antihistamine with a long clinical history. While it is not currently on the FDA's active drug shortage list, providers are increasingly fielding patient calls about difficulty locating specific pyrilamine-containing products — particularly prescription combination formulations with limited distribution. This guide summarizes the current availability landscape and provides clinically actionable guidance for 2026.

Current Availability Status

As of 2026, pyrilamine is not in an FDA-declared shortage. However, clinicians should be aware of the following nuances in the current market:

• Standalone pyrilamine tablets (e.g., Pyrlex 25 mg) are manufactured by small specialty companies with limited pharmacy distribution. Many major retail pharmacies do not stock them at all.
• Prescription combination formulations (e.g., phenylephrine/pyrilamine chewable tablets, codeine/phenylephrine/pyrilamine cough syrups) are made by small specialty pharma manufacturers, resulting in inconsistent regional stocking.
• OTC combination products (Midol Complete, Pamprin Multi-Symptom, Menstrual Relief generics) are broadly available at major retailers, though specific formulations or pack sizes may occasionally stock out.

Pharmacological Profile: Key Clinical Considerations

Pyrilamine is an ethylenediamine-class H1 inverse agonist. Clinically relevant features include:

• CNS penetration: Pyrilamine readily crosses the blood-brain barrier, producing significant sedation. This is both a therapeutic property (mild hypnosis) and a safety concern requiring patient counseling.
• Low anticholinergic burden: Notably, pyrilamine has 130,000-fold selectivity for H1 over muscarinic receptors — far greater selectivity than diphenhydramine (20-fold). This may make it preferable to diphenhydramine in patients with BPH, constipation, or dry mouth concerns.
• Drug interactions: Contraindicated with MAOIs. Additive CNS depression with alcohol, benzodiazepines, opioids, and other sedatives. May mask aminoglycoside-related ototoxicity.
• Pediatric caution: Paradoxical CNS excitation and convulsions have been reported in young children. Not recommended under age 12 without specific medical direction.

Therapeutic Alternatives When Pyrilamine Is Unavailable

When pyrilamine-containing products cannot be located, the following evidence-based alternatives may be considered based on the clinical indication:

For allergic rhinitis / urticaria:

• First-line: Cetirizine 5-10 mg daily, loratadine 10 mg daily, or fexofenadine 180 mg daily (all second-generation, minimal sedation)
• Sedating first-generation alternative: Diphenhydramine 25-50 mg every 4-6 hours or chlorpheniramine 4 mg every 4-6 hours

For upper respiratory combination (cold/allergy):

• Numerous OTC antihistamine/decongestant combinations with chlorpheniramine or diphenhydramine are readily available

For dysmenorrhea/PMS symptom relief:

• NSAIDs (ibuprofen 400 mg, naproxen sodium 220-440 mg) are generally superior to acetaminophen combinations for dysmenorrhea through prostaglandin inhibition
• Midol Extended Relief (naproxen sodium 220 mg) is an OTC alternative specifically marketed for menstrual pain

Counseling Points for Patients

When patients ask why they can't find their pyrilamine product, the following counseling points help set accurate expectations:

• Pyrilamine is not in a national shortage — the ingredient is available, but specific products may have limited local stocking
• OTC combination products (Midol, Pamprin) are widely available and do not require a prescription
• A special order from their current pharmacy may be the fastest path to obtaining a prescription combination product

Help Your Patients Find Pyrilamine Faster

Consider referring patients to medfinder for providers. medfinder contacts pharmacies near the patient on their behalf, checks stock of the specific product, and delivers results by text — reducing provider office calls and helping patients get their medication without delay.

See also: How to help your patients find pyrilamine in stock: A provider's guide.